The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up.

por Toikkanen, S., Joensuu, H., Klemi, P.
Publicado 1989

Histological features, DNA content and prognosis of breast carcinoma found incidentally or in screening.

por Joensuu, H., Toikkanen, S., Klemi, P. J.
Publicado 1991

Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma.

por Joensuu, H., Ristamäki, R., Klemi, P. J., Jalkanen, S.
Publicado 1993

Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma.

por Klemi, P. J., Alanen, K., Jalkanen, S., Joensuu, H.
Publicado 1992

Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck.

por Inki, P., Joensuu, H., Grénman, R., Klemi, P., Jalkanen, M.
Publicado 1994

Mammography screening interval and the frequency of interval cancers in a population-based screening.

por Klemi, P. J., Toikkanen, S., Räsänen, O., Parvinen, I., Joensuu, H.
Publicado 1997

Predicting aggressive outcome in T1N0M0 breast cancer

por Kronqvist, P, Kuopio, T, Nykänen, M, Helenius, H, Anttinen, J, Klemi, P
Publicado 2004

Mammography screening in three Finnish residential areas: comprehensive population-based study of breast cancer incidence and incidence-based mortality 1976–2009

por Parvinen, I, Heinävaara, S, Anttila, A, Helenius, H, Klemi, P, Pylkkänen, L
Publicado 2015

Effects of annual vs triennial mammography interval on breast cancer incidence and mortality in ages 40–49 in Finland

por Parvinen, I, Chiu, S, Pylkkänen, L, Klemi, P, Immonen-Räihä, P, Kauhava, L, Malila, N, Hakama, M
Publicado 2011

A missense mutation in the BRCA2 gene in three siblings with ovarian cancer.

por Roth, S., Kristo, P., Auranen, A., Shayehgi, M., Seal, S., Collins, N., Barfoot, R., Rahman, N., Klemi, P. J., Grénman, S., Sarantaus, L., Nevanlinna, H., Butzow, R., Ashworth, A., Stratton, M. R., Aaltonen, L. A.
Publicado 1998